Questions or concerns about cancer?Contact the Cancer Nurseline
Mon - Fri 9 am - 5 pmEmail
Prostate cancer is the most common cancer in Irish men and the second most common cause of cancer death. Laboratory studies have suggested that digoxin, a drug obtained from the digitalis plant and commonly used for the treatment of heart conditions, may have a role to play in the prevention and treatment of prostate cancer. Other studies have proposed that aspirin use may be associated with reduced risk of cancer death. This research has investigated, in a cohort of Irish prostate cancer patients, whether men receiving digoxin or aspirin had improved outcomes compared to men who didn't receive these medicines.
Prostate cancer is a disease for which there is few effective treatment options. Recent studies have identified that two commonly utilised and commercially available drugs, namely digoxin and aspirin, may play a role in the prevention of prostate cancer. This project aims to further examine the preventive nature of these two drugs in prostate cancer patients and determine if taking digoxin or aspirin has any effect on the number of prostate cancer deaths.
Irish Cancer Society, 43/45 Northumberland Road, Dublin, D04 VX65, IrelandTel +353 (0)1 2310 500 | email@example.comCRO 20868; CHY 5863; CRA 20009502
© Irish Cancer Society 1999-2018